Winway Health Desk
Secrets to Pop Health Management success: Take a leap of faith,...
As reimbursement increasingly shifts away from treating specific conditions and toward value-based care, considering a patient’s holistic health journey via population health management (PHM)...
AI algorithm for detecting prostate cancer shows more than 98% sensitivity,...
An Israeli startup developing a digital pathology system based around artificial intelligence has published what it calls “outstanding outcomes” in a clinical validation study.
Tel...
AstraZeneca’s Farxiga cuts serious events by half in patients with chronic...
AstraZeneca has shaken up the lucrative heart failure market with diabetes med Farxiga after a major approval earlier this year. But in kidney disease, another...
Two years after reset, Withings turns focus to remote patient monitoring...
Withings, which makes an array of smart scales, blood pressure monitors, and other connected health devices, raised $60 million in funding. Photo credit: Withings
With...
Pfizer, BioNTech start late-stage study of Covid-19 vaccine
Just a day after the launch of the first Phase III study of a vaccine against the virus that causes Covid-19, two other companies...
What Parents Need to Know About Hand Sanitizers in 2020
We’ve written about the potential dangers of hand sanitizer before, as adverse exposure to it is...
FDA Approves Xeglyze (abametapir) Lotion for the Treatment of Head Lice
FDA Approves Xeglyze (abametapir) Lotion for the Treatment of Head Lice
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE) July 27, 2020 --Dr. Reddy’s Laboratories Ltd. today...
Kaiser Permanente opens new medical school in Pasadena
Kaiser Permanente brought in its first class of 50 students to its new medical school this week. Photo credit: Kaiser Permanente
Kaiser Permanente’s new medical...
With $200M in new funding, Ro looks to become patients’ first...
Online health startup Ro raised $200 million in funding. Photo credit: Ro
With $200 million in new funding, online clinic Ro is broadening its focus...
Pfizer could earn $15B-plus in COVID-19 vaccine sales: analyst
On the heels of Pfizer's $1.95 billion COVID-19 vaccine deal with the U.S. government, one analyst says the drugmaker could earn many more billions...
